Breakthrough in Cancer Treatment: FDA approves CAR-T Immunotherapy

The advisers of US Food and Drug Administration (FDA) gave their nod to CAR-T Immunotherapy for treating different forms of cancers.This therapy genetically engineers the patient’s own immune cells to target the cancerous ones and destroy them.